Impact of Severe Hepatic Impairment on Pharmacokinetics of Cenicriviroc and Its Metabolites
Clinical trial NCT03376841 · COMPLETED
Trial details
- NCT number
- NCT03376841
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-06
- Primary completion
- 2017-11-24
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.